Provided by Tiger Trade Technology Pte. Ltd.

AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF

27.00
+0.30111.13%
Post-market: 27.000.00000.00%16:10 EDT
Volume:392
Turnover:10.60K
Market Cap:5.40M
PE:- -
High:27.00
Open:27.00
Low:27.00
Close:26.70
52wk High:27.94
52wk Low:22.63
Shares:200.00K
Float Shares:200.00K
Volume Ratio:0.61
T/O Rate:0.20%
Dividend:0.41
Dividend Rate:1.53%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Insulet Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 15

Eli Lilly & Co. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 15

Scholar Rock Grants Inducement Equity Awards for 51,947 Shares to 12 New Hires

Reuters
·
Aug 15

Scholar Rock Reports New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 15

Eli Lilly’s New Phase 1 Study Signals Ongoing Pipeline Expansion

TIPRANKS
·
Aug 15

Lilly Expands Obesity Pipeline With Fresh Macupatide Trial in Japan

TIPRANKS
·
Aug 15

China Merchants Adjusts Eli Lilly Price Target to $1,252 From $964, Maintains Buy Rating

MT Newswires Live
·
Aug 14

UBS Pursues Dual Strategy in Q2: Betting on AI Compute Boom While Hedging Crowded Trade Risks

Stock News
·
Aug 14

Eli Lilly & Co (LLY) Gets a Buy from Barclays

TIPRANKS
·
Aug 14

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Ascendis Pharma (ASND)

TIPRANKS
·
Aug 14

Sands Capital boosts Eli Lilly stake with 12,445 shares

TIPRANKS
·
Aug 14

'It Feels Like a Medical Miracle': How Did a Single QR Code Coupon Cut My $618 Walgreens Prescription to $15?

Dow Jones
·
Aug 14

Aktis Oncology Q2 FY26 Net Loss Widens 33.15% to $24.1 Million

Reuters
·
Aug 14

Novo Nordisk Completes Key Oral Semaglutide Study in Japan: What Investors Should Watch

TIPRANKS
·
Aug 14

Novo Nordisk’s SEMA-CardioDiab Hungary Study: What Real-World Oral Semaglutide Data Could Mean for NVO Investors

TIPRANKS
·
Aug 14

Novo Nordisk A/S Series B Stock Falls Thursday, Underperforms Market

Dow Jones
·
Aug 14

Scholar Rock Holding Price Target Raised to $63.00/Share from $56.00 by JP Morgan

Dow Jones
·
Aug 13

European Equities Traded in the US Rise in Thursday Trading

MT Newswires Live
·
Aug 13

Novo Nordisk CEO Defends Lawsuit Against Eli Lilly (LLY)

TIPRANKS
·
Aug 13

Novo CEO Says Obesity Market Won't be Winner-Take-All Battle with Lilly

Reuters
·
Aug 13